{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:23:11Z","timestamp":1761502991000,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.yebeh.2008.06.010","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T04:54:16Z","timestamp":1216443256000},"page":"470-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration"],"prefix":"10.1016","volume":"13","author":[{"given":"Kirsten A.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erling","family":"T\u00f8mmerup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarke \u00e1 Rogvi","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Erdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2008.06.010_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00044011-199918010-00003","article-title":"Clinical problems with generic antiepileptic drugs: comparison of sustained-release formulations of carbamazepine","volume":"18","author":"Mayer","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.yebeh.2008.06.010_bib2","first-page":"284","article-title":"Steady state concentrations and diurnal fluctuations of carbamazepine in patients with different slow release formulations","volume":"42","author":"Wolf","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.yebeh.2008.06.010_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.seizure.2007.11.023","article-title":"Lamotrigine therapeutic thresholds","volume":"17","author":"S\u00f8ndergaard Khinchi","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.06.010_bib4","series-title":"Antiepileptic drugs","first-page":"380","article-title":"Lamotrigine, interaction with other drugs","author":"Garnett","year":"2002"},{"key":"10.1016\/j.yebeh.2008.06.010_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0920-1211(91)90012-5","article-title":"Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy","volume":"10","author":"Ramsay","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2008.06.010_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007691-199610000-00001","article-title":"Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication","volume":"18","author":"May","year":"1996","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2008.06.010_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1592\/phco.26.5.627","article-title":"Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers","volume":"26","author":"Jann","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yebeh.2008.06.010_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2125.2006.02598.x","article-title":"Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects","volume":"61","author":"Sidhu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2008.06.010_bib9","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/sj.npp.1300831","article-title":"Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine","volume":"30","author":"Theis","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2008.06.010_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1528-1157.2003.64402.x","article-title":"Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.06.010_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1528-1167.2007.01274.x","article-title":"Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy: the COMPASS Study","volume":"49","author":"Tompson","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.06.010_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yebeh.2008.02.020","article-title":"Comparative daily profiles with different preparations of lamotrigine: a pilot investigation","volume":"13","author":"Nielsen","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.010_bib13","unstructured":"http:\/\/www.laegemiddelstyrelsen.dk\/1024\/visL5Artikel.asp?artikelID=10139."},{"key":"10.1016\/j.yebeh.2008.06.010_bib14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2008.06.010_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1525-5050(03)00151-3","article-title":"Postictal serum levels of antiepileptic drugs for detection of non-compliance","volume":"4","author":"Specht","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.010_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2125.1997.00594.x","article-title":"Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data","volume":"43","author":"Hussein","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2008.06.010_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00228-006-0144-9","article-title":"Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring","volume":"62","author":"Almeida","year":"2006","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505008001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505008001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:19:15Z","timestamp":1761502755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505008001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1525505008001960"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2008.06.010","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2008.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}